These 3 shares are up 400% in 12 months

Over the last 12 months the All Ordinaries (Index: ^AXAO) (ASX: XAO) has managed to carve out a solid gain of approximately 4.8% excluding dividends.

Were you to add in dividends, this return would increase to around 8.8%.

Whilst that is a decent annual return, it pales in comparison to some of the returns being made on the index.

Especially those of the three shares listed below which have climbed at least 400% over the last 12 months. Here’s why they have been on fire:

The Bubs Australia Ltd (ASX: BUB) share price is up 450% since this time last year. Investors have been fighting to get hold of the goat milk infant formula company’s shares on the belief that it could be the next A2 Milk Company Ltd (ASX: A2M). I’ve been very impressed at the progress the company has made on its distribution network over the last 12 months and can’t say I’m surprised by the share price rise. However, until its sales start to justify its sizeable market capitalisation, I intend to hold off an investment.

The Cann Group Ltd (ASX: CAN) share price has stormed 400% higher since this time last year. The medicinal cannabis company’s shares have been on a tear due partly to the loosening of regulations around exports and medical usage in Australia. Investors may believe that Cann’s enormous growing facilities have positioned it perfectly to profit from export markets. In addition to this, the company recently confirmed that it had held preliminary discussions with Canadian giant Aurora Cannabis about a potential transaction. Although no financial details were revealed and it is still at a very early stage, there is speculation that it could be at a price of $4.50 per share. This would value Cann at approximately $500 million.

The Ltd (ASX: KGN) share price has rocketed 450% higher over the last 12 months. The market appears to have been thoroughly impressed at the way Kogan has smashed its prospectus forecasts. Furthermore, the diversification of its business into offering mobile, internet, and insurance products has been well-received. But after such a strong share price gain, I think its shares are about fair value at 61x estimated forward earnings. I intend to wait in hope of a pullback in its share price before making a move.

Looking for the next stars of the ASX? Then look no further than these three growth shares.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.